198 related articles for article (PubMed ID: 18192912)
1. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
[TBL] [Abstract][Full Text] [Related]
2. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
3. Effects of mycophenolic acid on inosine monophosphate dehydrogenase I and II mRNA expression in white blood cells and various tissues in sheep.
Dzidic A; Prgomet C; Mohr A; Meyer K; Bauer J; Meyer HH; Pfaffl MW
J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):163-9. PubMed ID: 16629948
[TBL] [Abstract][Full Text] [Related]
4. Expression of IMPDH1 is regulated in response to mycophenolate concentration.
Bremer S; Vethe NT; Rootwelt H; Bergan S
Int Immunopharmacol; 2009 Feb; 9(2):173-80. PubMed ID: 19010451
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.
Bremer S; Vethe NT; Rootwelt H; Jørgensen PF; Stenstrøm J; Holdaas H; Midtvedt K; Bergan S
J Transl Med; 2009 Jul; 7():64. PubMed ID: 19635156
[TBL] [Abstract][Full Text] [Related]
6. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
Vethe NT; Bremer S; Bergan S
Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
[TBL] [Abstract][Full Text] [Related]
7. Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells.
Glander P; Sombogaard F; Budde K; van Gelder T; Hambach P; Liefeldt L; Lorkowski C; Mai M; Neumayer HH; Vulto AG; Mathot RA
Ther Drug Monit; 2009 Jun; 31(3):351-9. PubMed ID: 19333146
[TBL] [Abstract][Full Text] [Related]
8. Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells.
Bremer S; Rootwelt H; Bergan S
Clin Chem; 2007 Jun; 53(6):1023-9. PubMed ID: 17463174
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T>C gene polymorphism.
Pazik J; Ołdak M; Podgórska M; Lewandowski Z; Sitarek E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
Transplant Proc; 2011 Oct; 43(8):2943-5. PubMed ID: 21996196
[TBL] [Abstract][Full Text] [Related]
10. Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation.
Raggi MC; Siebert SB; Steimer W; Schuster T; Stangl MJ; Abendroth DK
Transplantation; 2010 Dec; 90(12):1536-41. PubMed ID: 21076373
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.
Weimert NA; Derotte M; Alloway RR; Woodle ES; Vinks AA
Ther Drug Monit; 2007 Apr; 29(2):141-9. PubMed ID: 17417067
[TBL] [Abstract][Full Text] [Related]
12. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.
Vethe NT; Mandla R; Line PD; Midtvedt K; Hartmann A; Bergan S
Scand J Clin Lab Invest; 2006; 66(1):31-44. PubMed ID: 16464785
[TBL] [Abstract][Full Text] [Related]
13. Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.
Neuberger M; Sommerer C; Böhnisch S; Metzendorf N; Mehrabi A; Stremmel W; Gotthardt D; Zeier M; Weiss KH; Rupp C
Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):543-550. PubMed ID: 31924555
[TBL] [Abstract][Full Text] [Related]
14. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.
Chiarelli LR; Molinaro M; Libetta C; Tinelli C; Cosmai L; Valentini G; Dal Canton A; Regazzi M
Br J Clin Pharmacol; 2010 Jan; 69(1):38-50. PubMed ID: 20078611
[TBL] [Abstract][Full Text] [Related]
15. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.
Wang J; Yang JW; Zeevi A; Webber SA; Girnita DM; Selby R; Fu J; Shah T; Pravica V; Hutchinson IV; Burckart GJ
Clin Pharmacol Ther; 2008 May; 83(5):711-7. PubMed ID: 17851563
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function.
Petrova DT; Brandhorst G; Brehmer F; Gross O; Oellerich M; Armstrong VW
Ther Drug Monit; 2010 Aug; 32(4):405-12. PubMed ID: 20592645
[TBL] [Abstract][Full Text] [Related]
17. Expression of inosine monophosphate dehydrogenase type I and type II after mycophenolate mofetil treatment: a 2-year follow-up in kidney transplantation.
Sanquer S; Maison P; Tomkiewicz C; Macquin-Mavier I; Legendre C; Barouki R; Lang P
Clin Pharmacol Ther; 2008 Feb; 83(2):328-35. PubMed ID: 17713475
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.
Langman LJ; LeGatt DF; Halloran PF; Yatscoff RW
Transplantation; 1996 Sep; 62(5):666-72. PubMed ID: 8830834
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid.
Vethe NT; Ali AM; Reine PA; Andersen AM; Bremer S; Line PD; Rootwelt H; Bergan S
Ther Drug Monit; 2014 Feb; 36(1):108-18. PubMed ID: 24061448
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
